In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Can Artificial Intelligence Help Find Better Medicines?

Executive Summary

Artificial intelligence won’t transform pharma R&D, at least not anytime soon. But it is already impacting health care delivery and clinical trials.


Related Content

Finance Watch: Despite Bad News, IPOs And Public Offerings Keep Flowing
Novartis CEO-Designate Set To Bring More Automation To Drug Discovery
UK Medtech Market Access In Practice: Aim High But Stay Grounded
What Artificial Intelligence Brings To Drug Discovery – Sanofi Interview
Harnessing AI For Drug Development – UK's BenevolentAI And MRCT Link
One Size No Longer Fits All: The Personalized Medicine Trial Landscape
Watson Health And Pfizer Partner To Harness Big Data For Drug Discovery
Synthetic Biology And The Computerization Of Drug Development
In Silico Drug Design: Finally Ready For Prime Time?


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts